Health
Report: Moderna Sets Price Range for Coronavirus Vaccine – Motley Fool
If and when mRNA-1273 becomes available, it will apparently be relatively expensive.
Considered by many observers to be the leader in the hunt for a coronavirus vaccine, Moderna(NASDAQ:MRNA) has apparently settled on a price for its potential blockbuster product. Citing “people familiar with talks between the company and potential buyers,” the Financial Times reported Tuesday that the company aims to sell its vaccine at roughly $50 to $60 per two-dose treatment course.
That price applies to relatively prosperous countries such as the U.S. The article quoted “other people famili…
Continue Reading
